Trial Profile
A Pilot Study of Clofarabine Pre-Conditioning Prior to Full or Reduced Intensity Allogeneic Transplantation in the Treatment of High Risk Acute Myeloid Leukaemia and Myelodysplasia.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Sep 2018
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 05 Sep 2018 Status changed from active, no longer recruiting to completed.
- 12 Oct 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2017.
- 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.